Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 261425, 8 pages
http://dx.doi.org/10.1155/2015/261425
Review Article

Honey in the Prevention and Treatment of Infection in the CKD Population: A Narrative Review

1Department of Renal Medicine, Princess Alexandra Hospital, Brisbane, QLD 4102, Australia
2University of Sydney, Sydney, NSW 2006, Australia
3Centre for Kidney Disease Research, Translational Research Institute, University of Queensland, Brisbane, QLD 4102, Australia

Received 27 April 2015; Accepted 11 June 2015

Academic Editor: Juraj Majtan

Copyright © 2015 Anna Francis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. I. McDonald, S. L. Thomas, and D. Nitsch, “Chronic kidney disease as a risk factor for acute community-acquired infections in high-income countries: a systematic review,” BMJ Open, vol. 4, no. 4, Article ID e004100, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. C. von Eiff, W. Kohnen, K. Becker, and B. Jansen, “Modern strategies in the prevention of implant-associated infections,” The International Journal of Artificial Organs, vol. 28, no. 11, pp. 1146–1156, 2005. View at Google Scholar · View at Scopus
  3. K. Pugh-Clarke, S. Donlon, and M. McCann, “CE: continuing education article-prevention of infection in patients with chronic kidney disease part 1: application of infection control principles to the renal care environment,” Journal of Renal Care, vol. 36, no. 4, pp. 191–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. S. Dalrymple and A. S. Go, “Epidemiology of acute infections among patients with chronic kidney disease,” Clinical Journal of the American Society of Nephrology, vol. 3, no. 5, pp. 1487–1493, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. L. L. Silver, “Challenges of antibacterial discovery,” Clinical Microbiology Reviews, vol. 24, no. 1, pp. 71–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. C. D'Agata, “Antimicrobial-resistant, gram-positive bacteria among patients undergoing chronic hemodialysis,” Clinical Infectious Diseases, vol. 35, no. 10, pp. 1212–1218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. A. C. Hadley, T. B. Karchmer, G. B. Russell, D. G. McBride, and B. I. Freedman, “The prevalence of resistant bacterial colonization in chronic hemodialysis patients,” American Journal of Nephrology, vol. 27, no. 4, pp. 352–359, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Karou, W. M. C. Nadembega, L. Ouattara et al., “African ethnopharmacology and new drug discovery,” Medicinal and Aromatic Plant Science and Biotechnology, no. 1, pp. 61–60, 2007. View at Google Scholar
  9. N. Namias, “Honey in the management of infections,” Surgical Infections, vol. 4, no. 2, pp. 219–226, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Bose, “Honey or sugar in treatment of infected wounds?” The Lancet, vol. 1, no. 8278, article 963, 1982. View at Google Scholar · View at Scopus
  11. Z. H. Israili, “Antimicrobial properties of honey,” The American Journal of Therapeutics, vol. 21, no. 4, pp. 304–323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Boukraâa and S. A. Sulaiman, “Rediscovering the antibiotics of the hive,” Recent Patents on Anti-Infective Drug Discovery, vol. 4, no. 3, pp. 206–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. E. Blair, N. N. Cokcetin, E. J. Harry, and D. A. Carter, “The unusual antibacterial activity of medical-grade Leptospermum honey: antibacterial spectrum, resistance and transcriptome analysis,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 28, no. 10, pp. 1199–1208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. J. van den Berg, E. van den Worm, H. C. Q. van Ufford, S. B. Halkes, M. J. Hoekstra, and C. J. Beukelman, “An in vitro examination of the antioxidant and anti-inflammatory properties of buckwheat honey,” Journal of wound care, vol. 17, no. 4, pp. 172–178, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. P. E. Lusby, A. L. Coombes, and J. M. Wilkinson, “Bactericidal activity of different honeys against pathogenic bacteria,” Archives of Medical Research, vol. 36, no. 5, pp. 464–467, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Tonks, R. A. Cooper, A. J. Price, P. C. Molan, and K. P. Jones, “Stimulation of TNF-alpha release in monocytes by honey,” Cytokine, vol. 14, no. 4, pp. 240–242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. A. J. Tonks, R. A. Cooper, K. P. Jones, S. Blair, J. Parton, and A. Tonks, “Honey stimulates inflammatory cytokine production from monocytes,” Cytokine, vol. 21, no. 5, pp. 242–247, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. A. Zaghloul, H. H. El-Shattawy, A. A. Kassem, E. A. Ibrahim, I. K. Reddy, and M. A. Khan, “Honey, a prospective antibiotic: extraction, formulation, and stability,” Pharmazie, vol. 56, no. 8, pp. 643–647, 2001. View at Google Scholar · View at Scopus
  19. H. T. Tan, R. A. Rahman, S. H. Gan et al., “The antibacterial properties of Malaysian tualang honey against wound and enteric microorganisms in comparison to manuka honey,” BMC Complementary & Alternative Medicine, vol. 9, article 34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Mavric, S. Wittmann, G. Barth, and T. Henle, “Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand,” Molecular Nutrition and Food Research, vol. 52, no. 4, pp. 483–489, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. D. Mandal and S. Mandal, “Honey: its medicinal property and antibacterial activity,” Asian Pacific Journal of Tropical Biomedicine, vol. 1, no. 2, pp. 154–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Hampton, A. Coulborn, M. Tadej, and C. Bree-Aslan, “Using a superabsorbent dressing and antimicrobial for a venous ulcer,” British Journal of Nursing, vol. 20, no. 15, pp. S38–S43, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Chatzoulis, K. Chatzoulis, P. Spyridopoulos, P. Pappas, and A. Ploumis, “Salvage of an infected titanium mesh in a large incisional ventral hernia using medicinal honey and vacuum-assisted closure: a case report and literature review,” Hernia, vol. 16, no. 4, pp. 475–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. N. S. Al-Waili, “Investigating the antimicrobial activity of natural honey and its effects on the pathogenic bacterial infections of surgical wounds and conjunctiva,” Journal of Medicinal Food, vol. 7, no. 2, pp. 210–222, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Kassim, K. M. Yusoff, G. Ong, S. Sekaran, M. Y. B. M. Yusof, and M. Mansor, “Gelam honey inhibits lipopolysaccharide-induced endotoxemia in rats through the induction of heme oxygenase-1 and the inhibition of cytokines, nitric oxide, and high-mobility group protein B1,” Fitoterapia, vol. 83, no. 6, pp. 1054–1059, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. S. Bischofberger, C. M. Dart, N. R. Perkins, A. Kelly, L. Jeffcott, and A. J. Dart, “The effect of short- and long-term treatment with manuka honey on second intention healing of contaminated and noncontaminated wounds on the distal aspect of the forelimbs in horses,” Veterinary Surgery, vol. 42, no. 2, pp. 154–160, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Oelschlaegel, L. Pieper, R. Staufenbiel et al., “Floral markers of cornflower (Centaurea cyanus) honey and its peroxide antibacterial activity for an alternative treatment of digital dermatitis,” Journal of Agricultural & Food Chemistry, vol. 60, no. 47, pp. 11811–11820, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. E. E. Efem, K. T. Udoh, and C. I. Iwara, “The antimicrobial spectrum of honey and its clinical significance,” Infection, vol. 20, no. 4, pp. 227–229, 1992. View at Publisher · View at Google Scholar · View at Scopus
  29. P. H. S. Kwakman, J. P. C. van den Akker, A. Güçlü et al., “Medical-grade honey kills antibiotic-resistant bacteria in vitro and eradicates skin colonization,” Clinical Infectious Diseases, vol. 46, no. 11, pp. 1677–1682, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Basualdo, V. Sgroy, M. S. Finola, and J. M. Marioli, “Comparison of the antibacterial activity of honey from different provenance against bacteria usually isolated from skin wounds,” Veterinary Microbiology, vol. 124, no. 3-4, pp. 375–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. V. Mullai and T. Menon, “Bactericidal activity of different types of honey against clinical and environmental isolates of Pseudomonas aeruginosa,” Journal of Alternative & Complementary Medicine, vol. 13, no. 4, pp. 439–441, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Boukraâ and S. Bouchegrane, “Additive action of honey and starch against Candida albicans and Aspergillus niger,” Revista Iberoamericana de Micología, vol. 24, no. 4, pp. 309–311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Maeda, A. Loughrey, J. A. P. Earle et al., “Antibacterial activity of honey against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA),” Complementary Therapies in Clinical Practice, vol. 14, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Müller, D. G. Alber, L. Turnbull et al., “Synergism between Medihoney and rifampicin against methicillin-resistant Staphylococcus aureus (MRSA),” PLoS ONE, vol. 8, no. 2, Article ID e57679, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Jenkins and R. Cooper, “Improving antibiotic activity against wound pathogens with manuka honey in vitro,” PLoS ONE, vol. 7, no. 9, Article ID e45600, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. S. D. Deshpande and K. S. Kulkarni, “In vitro effect of some Indian honeys on Staphylococcus aureus from wounds,” Indian Journal of Experimental Biology, vol. 48, no. 9, pp. 931–935, 2010. View at Google Scholar · View at Scopus
  37. R. Cooper and R. Jenkins, “Are there feasible prospects for manuka honey as an alternative to conventional antimicrobials?” Expert Review of Anti-Infective Therapy, vol. 10, no. 6, pp. 623–625, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. N.-A. M. Nasir, A. S. Halim, K.-K. B. Singh, A. A. Dorai, and M.-N. M. Haneef, “Antibacterial properties of tualang honey and its effect in burn wound management: a comparative study,” BMC Complementary & Alternative Medicine, vol. 10, article 31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. D. J. Willix, P. C. Molan, and C. G. Harfoot, “A comparison of the sensitivity of wound-infecting species of bacteria to the antibacterial activity of manuka honey and other honey,” Journal of Applied Bacteriology, vol. 73, no. 5, pp. 388–394, 1992. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Tasleem, S. B. Naqvi, S. A. Khan, and K. Hashmi, “Efficacy of newly formulated ointment containing 20% active antimicrobial honey in treatment of burn wound infections,” Journal of Ayub Medical College Abbottabad, vol. 25, no. 1-2, pp. 145–148, 2013. View at Google Scholar
  41. K. I. Malik, M. A. N. Malik, and A. Aslam, “Honey compared with silver sulphadiazine in the treatment of superficial partial-thickness burns,” International Wound Journal, vol. 7, no. 5, pp. 413–417, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Simon, K. Sofka, G. Wiszniewsky, G. Blaser, U. Bode, and G. Fleischhack, “Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology,” Supportive Care in Cancer, vol. 14, no. 1, pp. 91–97, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. D. W. Johnson, S. V. Badve, E. M. Pascoe et al., “Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial,” The Lancet Infectious Diseases, vol. 14, no. 1, pp. 23–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Alam, M. A. Islam, S. H. Gan, and M. I. Khalil, “Honey: a potential therapeutic agent for managing diabetic wounds,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 169130, 16 pages, 2014. View at Publisher · View at Google Scholar
  45. A. Rudzka-Nowak, P. Luczywek, M. J. Gajos, and M. Piechota, “Application of manuka honey and GENADYNE A4 negative pressure wound therapy system in a 55-year-old woman with extensive phlegmonous and necrotic lesions in the abdominal integuments and lumbar region after traumatic rupture of the colon,” Case Reports and Clinical Practice Review, vol. 16, no. 11, pp. CS138–CS142, 2010. View at Google Scholar · View at Scopus
  46. G. Blaser, K. Santos, U. Bode, H. Vetter, and A. Simon, “Effect of medical honey on wounds colonised or infected with MRSA,” Journal of wound care, vol. 16, no. 8, pp. 325–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Chambers, “Topical manuka honey for MRSA-contaminated skin ulcers,” Palliative Medicine, vol. 20, no. 5, article 557, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Vardi, Z. Barzilay, N. Linder, H. A. Cohen, G. Paret, and A. Barzilai, “Local application of honey for treatment of neonatal postoperative wound infection,” Acta Paediatrica, International Journal of Paediatrics, vol. 87, no. 4, pp. 429–432, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Phuapradit and N. Saropala, “Topical application of honey in treatment of abdominal wound disruption,” Australian & New Zealand Journal of Obstetrics & Gynaecology, vol. 32, no. 4, pp. 381–384, 1992. View at Publisher · View at Google Scholar · View at Scopus
  50. S. E. E. Efem, “Clinical observations on the wound healing properties of honey,” British Journal of Surgery, vol. 75, no. 7, pp. 679–681, 1988. View at Publisher · View at Google Scholar · View at Scopus
  51. S. Natarajan, D. Williamson, J. Grey, K. G. Harding, and R. A. Cooper, “Healing of an MRSA-colonized, hydroxyurea-induced leg ulcer with honey,” Journal of Dermatological Treatment, vol. 12, no. 1, pp. 33–36, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Clayton, “Transplantation report,” ANZDATA Registry Report 2012, 2012. View at Google Scholar
  53. A. B. Jull, N. Cullum, J. C. Dumville, M. J. Westby, S. Deshpande, and N. Walker, “Honey as a topical treatment for wounds,” Cochrane Database of Systematic Reviews, no. 3, Article ID CD005083, 2015. View at Google Scholar
  54. A. B. Jull, N. Walker, and S. Deshpande, “Honey as a topical treatment for wounds,” Cochrane Database of Systematic Reviews, vol. 8, no. 4, Article ID CD005083, 2013. View at Google Scholar · View at Scopus
  55. R. Ingle, J. Levin, and K. Polinder, “Wound healing with honey—a randomised controlled trial,” South African Medical Journal, vol. 96, no. 9, pp. 831–835, 2006. View at Google Scholar · View at Scopus
  56. A. Jull, N. Walker, V. Parag, P. Molan, and A. Rodgers, “Randomized clinical trial of honey-impregnated dressings for venous leg ulcers,” British Journal of Surgery, vol. 95, no. 2, pp. 175–182, 2008. View at Google Scholar
  57. G. Gethin and S. Cowman, “Bacteriological changes in sloughy venous leg ulcers treated with manuka honey or hydrogel: an RCT,” Journal of Wound Care, vol. 17, no. 6, pp. 241–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. B. K. H. L. Boekema, L. Pool, and M. M. W. Ulrich, “The effect of a honey based gel and silver sulphadiazine on bacterial infections of in vitro burn wounds,” Burns, vol. 39, no. 4, pp. 754–759, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. D. Henatsch, F. Wesseling, J. J. Briedé, and R. J. Stokroos, “Treatment of chronically infected open mastoid cavities with medical honey: a randomized controlled trial,” Otology & Neurotology, vol. 36, no. 5, pp. 782–787, 2015. View at Publisher · View at Google Scholar
  60. M. Cernak, N. Majtanova, A. Cernak, and J. Majtan, “Honey prophylaxis reduces the risk of endophthalmitis during perioperative period of eye surgery,” Phytotherapy Research, vol. 26, no. 4, pp. 613–616, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. F. Hashemian, N. Baghbanian, Z. Majd, M. Rouini, J. Jahanshahi, and F. Hashemian, “The effect of thyme honey nasal spray on chronic rhinosinusitis: a double-blind randomized controlled clinical trial,” European Archives of Oto-Rhino-Laryngology, vol. 272, no. 6, pp. 1429–1435, 2015. View at Publisher · View at Google Scholar
  62. J. Bardy, A. Molassiotis, W. D. Ryder et al., “A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis,” British Journal of Oral & Maxillofacial Surgery, vol. 50, no. 3, pp. 221–226, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Uwaydat, P. Jha, R. Tytarenko et al., “The use of topical honey in the treatment of corneal abrasions and endotoxin-induced keratitis in an animal model,” Current Eye Research, vol. 36, no. 9, pp. 787–796, 2011. View at Publisher · View at Google Scholar · View at Scopus
  64. P. C. Molan and K. L. Allen, “The effect of gamma-irradiation on the antibacterial activity of honey,” Journal of Pharmacy & Pharmacology, vol. 48, no. 11, pp. 1206–1209, 1996. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Tuncel, P. Uysal, A. B. Hocaoglu et al., “Anaphylaxis caused by honey ingestion in an infant,” Allergologia et Immunopathologia, vol. 39, no. 2, pp. 112–113, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Majtan, “Methylglyoxal—a potential risk factor of manuka honey in healing of diabetic ulcers,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 295494, 5 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. C. G. Cochrane, “Cellular injury by oxidants,” The American Journal of Medicine, vol. 91, no. 3, pp. 23S–30S, 1991. View at Google Scholar · View at Scopus
  68. L. M. Bang, C. Buntting, and P. Molan, “The effect of dilution on the rate of hydrogen peroxide production in honey and its implications for wound healing,” Journal of Alternative and Complementary Medicine, vol. 9, no. 2, pp. 267–273, 2003. View at Publisher · View at Google Scholar · View at Scopus
  69. S. B. Naqvi and A. J. Collins, “Infectious complications in chronic kidney disease,” Advances in Chronic Kidney Disease, vol. 13, no. 3, pp. 199–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. M. J. Sarnak and B. L. Jaber, “Mortality caused by sepsis in patients with end-stage renal disease compared with the general population,” Kidney International, vol. 58, no. 4, pp. 1758–1764, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. K. R. Polkinghorne, S. P. Mcdonald, R. C. Atkins, and P. G. Kerr, “Vascular access and all-cause mortality: a propensity score analysis,” Journal of the American Society of Nephrology, vol. 15, no. 2, pp. 477–486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  72. D. W. Johnson, H. Dent, C. M. Hawley et al., “Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand,” American Journal of Kidney Diseases, vol. 53, no. 2, pp. 290–297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. D. W. Johnson, R. MacGinley, T. D. Kay et al., “A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters,” Nephrology Dialysis Transplantation, vol. 17, no. 10, pp. 1802–1807, 2002. View at Publisher · View at Google Scholar · View at Scopus
  74. K. J. Wiggins, D. W. Johnson, J. C. Craig, and G. F. M. Strippoli, “Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials,” American Journal of Kidney Diseases, vol. 50, no. 6, pp. 967–988, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Piraino, J. Bernardini, E. Brown et al., “ISPD position statement on reducing the risks of peritoneal dialysis-related infections,” Peritoneal Dialysis International, vol. 31, no. 6, pp. 614–630, 2011. View at Publisher · View at Google Scholar · View at Scopus
  76. A. R. Nissenson, M. L. Dylan, R. I. Griffiths et al., “Clinical and economic outcomes of Staphylococcus aureus septicemia in ESRD patients receiving hemodialysis,” American Journal of Kidney Diseases, vol. 46, no. 2, pp. 301–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  77. K. Howard, A. Hayes, Y. Cho, A. Cass, M. Clarke, and D. W. Johnson, “Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ trial,” The American Journal of Kidney Diseases, vol. 65, no. 5, pp. 773–779, 2015. View at Publisher · View at Google Scholar
  78. A. C. Webster, G. Wong, J. C. Craig, and J. R. Chapman, “Managing cancer risk and decision making after kidney transplantation,” American Journal of Transplantation, vol. 8, no. 11, pp. 2185–2191, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. E. L. Pesanti, “Immunologic defects and vaccination in patients with chronic renal failure,” Infectious Disease Clinics of North America, vol. 15, no. 3, pp. 813–832, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Allon, T. A. Depner, M. Radeva et al., “Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO study,” Journal of the American Society of Nephrology, vol. 14, no. 7, pp. 1863–1870, 2003. View at Publisher · View at Google Scholar · View at Scopus
  81. P. McIntyre and J. C. Craig, “Prevention of serious bacterial infection in children with nephrotic syndrome,” Journal of Paediatrics and Child Health, vol. 34, no. 4, pp. 314–317, 1998. View at Publisher · View at Google Scholar · View at Scopus
  82. R. Vanholder and S. Ringoir, “Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review,” Journal of the American Society of Nephrology, vol. 3, no. 9, pp. 1541–1554, 1993. View at Google Scholar · View at Scopus
  83. G. Cohen, M. Haag-Weber, and W. H. Horl, “Immune dysfunction in uremia,” Kidney International Supplement, vol. 62, pp. S79–S82, 1997. View at Google Scholar
  84. J. R. Ghali, K. M. Bannister, F. G. Brown et al., “Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients,” Peritoneal Dialysis International, vol. 31, no. 6, pp. 651–662, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. W. F. Keane, F. L. Shapiro, and L. Raij, “Incidence and type of infections occurring in 445 chronic hemodialysis patients,” Transactions — American Society for Artificial Organs, vol. 23, pp. 41–47, 1977. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Aslam, F. Vaida, M. Ritter, and R. L. Mehta, “Systematic review and meta-analysis on management of hemodialysis catheter-related bacteremia,” Journal of the American Society of Nephrology, vol. 25, no. 12, pp. 2927–2941, 2014. View at Publisher · View at Google Scholar
  87. J. I. Tokars, T. Gehr, W. R. Jarvis et al., “Vancomycin-resistant enterococci colonization in patients at seven hemodialysis centers,” Kidney International, vol. 60, no. 4, pp. 1511–1516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. D. P. Calfee, “Multidrug-resistant organisms in dialysis patients,” Seminars in Dialysis, vol. 26, no. 4, pp. 447–456, 2013. View at Publisher · View at Google Scholar · View at Scopus
  89. D. W. Johnson, C. van Eps, D. W. Mudge et al., “Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1456–1462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. Queensland Infection Surveillance and Prevention Guidelines for Haemodialysis catheters, http://www.health.qld.gov.au/qhpolicy/docs/gdl/qh-gdl-321-6-4.pdf.
  91. R. Miles and D. W. Johnson, “Use of honey to prevent infections associated with medical devices,” in Honey: A Modern Wound Management Product, R. Cooper, P. Molan, and R. White, Eds., pp. 91–105, Wounds UK Books, Dorset, UK, 2008. View at Google Scholar
  92. K. H. Quadri and S. O. Huraib, “Manuka honey for central vein catheter exit site care,” Seminars in Dialysis, vol. 12, no. 5, pp. 396–399, 1999. View at Publisher · View at Google Scholar
  93. L. A. Mermel, M. Allon, E. Bouza et al., “Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the infectious diseases society of America,” Clinical Infectious Diseases, vol. 49, no. 1, pp. 1–45, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. M. McCann and Z. E. Moore, “Interventions for preventing infectious complications in haemodialysis patients with central venous catheters,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD006894, 2010. View at Google Scholar · View at Scopus
  95. M. Lotfy, G. Badra, W. Burham, and F. Q. Alenzi, “Combined use of honey, bee propolis and myrrh in healing a deep, infected wound in a patient with diabetes mellitus,” British Journal of Biomedical Science, vol. 63, no. 4, pp. 171–173, 2006. View at Google Scholar · View at Scopus
  96. M. F. Yuzbasioglu, E. B. Kurutas, E. Bulbuloglu et al., “Administration of honey to prevent peritoneal adhesions in a rat peritonitis model,” International Journal of Surgery, vol. 7, no. 1, pp. 54–57, 2009. View at Publisher · View at Google Scholar · View at Scopus
  97. V. Robson, J. Yorke, R. A. Sen, D. Lowe, and S. N. Rogers, “Randomised controlled feasibility trial on the use of medical grade honey following microvascular free tissue transfer to reduce the incidence of wound infection,” British Journal of Oral and Maxillofacial Surgery, vol. 50, no. 4, pp. 321–327, 2012. View at Publisher · View at Google Scholar · View at Scopus
  98. R. Cooper, P. Molan, L. Krishnamoorthy, and K. Harding, “Manuka honey used to heal a recalcitrant surgical wound,” European Journal of Clinical Microbiology & Infectious Diseases, vol. 20, no. 10, pp. 758–759, 2001. View at Publisher · View at Google Scholar · View at Scopus